ID

23930

Descripción

Atorvastatin in New Onset Type 1 Diabetes Mellitus (T1DM); ODM derived from: https://clinicaltrials.gov/show/NCT00529191

Link

https://clinicaltrials.gov/show/NCT00529191

Palabras clave

Versiones (1)
  1. 18/7/17 18/7/17 -
Subido en

18 de julio de 2017

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Type 1 Diabetes NCT00529191

Inglés

Eligibility Type 1 Diabetes NCT00529191

1 formularios  
Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
individuals 10-19 years of age (tanner stage ii or greater),
Descripción

ID.1

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0429602
UMLS CUI [1,2]
C0429602
UMLS CUI [1,3]
C0001779
the presence of one or more serum antibodies to islet cell proteins (anti- glutamic acid decarboxylase [gad], islet antigen 2 or insulin autoantibodies) as assessed in standard practice,
Descripción

ID.2

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C1522529
UMLS CUI [1,2]
C3203592
diagnosis of t1dm within the 8 weeks prior to study entry
Descripción

ID.3

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0011854
peak stimulated c-peptide level >0.2pmol/ml following mixed meal tolerance test (mmtt) performed at least 3 weeks after diagnosis,
Descripción

ID.4

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0202100
females of reproductive potential must not plan on conceiving a child during the treatment program, and agree to use a medically accepted form of contraception
Descripción

ID.5

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0700589
Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
subjects currently receiving cyclosporine, fibric acid derivatives, niacin (nicotinic acid), erythromycin, clarythromycin, nefazodone, itraconazole, ketoconazole or protease inhibitors,
Descripción

ID.6

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0010592
UMLS CUI [1,2]
C4020588
UMLS CUI [1,3]
C0027996
UMLS CUI [1,4]
C0014806
UMLS CUI [1,5]
C0055856
UMLS CUI [1,6]
C0068485
UMLS CUI [1,7]
C0022625
UMLS CUI [1,8]
C0033607
UMLS CUI [1,9]
C0064113
pregnancy or breast-feeding,
Descripción

ID.7

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0032961
UMLS CUI [1,2]
C0006147
clinical aids, aids related syndrome (ars) or known positive hiv serology,
Descripción

ID.8

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0001175
UMLS CUI [1,2]
C0019682
subjects treated with immunosuppressive therapy in the past 12 months,
Descripción

ID.9

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0021079
subjects receiving glucocorticoid therapy or therapy other than insulin that is likely to affect glucose homeostasis (such as sulfonylureas, thiazolidinediones, metformin or amylin),
Descripción

ID.10

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0744425
UMLS CUI [1,2]
C1326961
subjects with other autoimmune diseases, except autoimmune thyroid disease,
Descripción

ID.11

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0004364
subjects with any illness that might complicate diabetes management or preclude treatment with atorvastatin,
Descripción

ID.12

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0221423
transplant recipients,
Descripción

ID.13

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0376387
evidence of liver dysfunction or myopathy
Descripción

ID.14

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0026848
UMLS CUI [1,2]
C0086565
Volver a la parte superior de la página

Similar models

Eligibility Type 1 Diabetes NCT00529191

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
ID.1
Item
individuals 10-19 years of age (tanner stage ii or greater),
boolean
C0429602 (UMLS CUI [1,1])
C0429602 (UMLS CUI [1,2])
C0001779 (UMLS CUI [1,3])
ID.2
Item
the presence of one or more serum antibodies to islet cell proteins (anti- glutamic acid decarboxylase [gad], islet antigen 2 or insulin autoantibodies) as assessed in standard practice,
boolean
C1522529 (UMLS CUI [1,1])
C3203592 (UMLS CUI [1,2])
ID.3
Item
diagnosis of t1dm within the 8 weeks prior to study entry
boolean
C0011854 (UMLS CUI [1])
ID.4
Item
peak stimulated c-peptide level >0.2pmol/ml following mixed meal tolerance test (mmtt) performed at least 3 weeks after diagnosis,
boolean
C0202100 (UMLS CUI [1])
ID.5
Item
females of reproductive potential must not plan on conceiving a child during the treatment program, and agree to use a medically accepted form of contraception
boolean
C0700589 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
ID.6
Item
subjects currently receiving cyclosporine, fibric acid derivatives, niacin (nicotinic acid), erythromycin, clarythromycin, nefazodone, itraconazole, ketoconazole or protease inhibitors,
boolean
C0010592 (UMLS CUI [1,1])
C4020588 (UMLS CUI [1,2])
C0027996 (UMLS CUI [1,3])
C0014806 (UMLS CUI [1,4])
C0055856 (UMLS CUI [1,5])
C0068485 (UMLS CUI [1,6])
C0022625 (UMLS CUI [1,7])
C0033607 (UMLS CUI [1,8])
C0064113 (UMLS CUI [1,9])
ID.7
Item
pregnancy or breast-feeding,
boolean
C0032961 (UMLS CUI [1,1])
C0006147 (UMLS CUI [1,2])
ID.8
Item
clinical aids, aids related syndrome (ars) or known positive hiv serology,
boolean
C0001175 (UMLS CUI [1,1])
C0019682 (UMLS CUI [1,2])
ID.9
Item
subjects treated with immunosuppressive therapy in the past 12 months,
boolean
C0021079 (UMLS CUI [1])
ID.10
Item
subjects receiving glucocorticoid therapy or therapy other than insulin that is likely to affect glucose homeostasis (such as sulfonylureas, thiazolidinediones, metformin or amylin),
boolean
C0744425 (UMLS CUI [1,1])
C1326961 (UMLS CUI [1,2])
ID.11
Item
subjects with other autoimmune diseases, except autoimmune thyroid disease,
boolean
C0004364 (UMLS CUI [1])
ID.12
Item
subjects with any illness that might complicate diabetes management or preclude treatment with atorvastatin,
boolean
C0221423 (UMLS CUI [1])
ID.13
Item
transplant recipients,
boolean
C0376387 (UMLS CUI [1])
ID.14
Item
evidence of liver dysfunction or myopathy
boolean
C0026848 (UMLS CUI [1,1])
C0086565 (UMLS CUI [1,2])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial